Intelligent Trials

The clinical trial landscape is more complex and challenged than ever. Past success and practices are no longer sufficient predictors of future success. Medidata AI Intelligent Trials brings AI enabled technology, partnered with advanced analytics, to meet the challenges of this ever-changing landscape. Our clinical trial analytics solution brings together cross-industry real-time performance metrics, predictive models, and forecasting capabilities to give you a competitive edge in trial planning and execution.



Benefits of Clinical Trial Analytics

Use real-time, cross-industry data

Work with real-time data less than 1 month old on 7,000+ active trials, with access to cross-industry trials (50% oncology, 50% non-oncology). The data set is unique, standardized, diverse, and built to complement your company and real-world data. Utilizing this broader set of data allows you to measure the impact of change and adjust your trial as needed.

Gain a competitive edge

Identify the best site locations today for successful patient recruitment to meet and accelerate target patient enrollments, diversify your targets, and assess rates of congestion at sites. Thus, giving you the ability to quickly assess the impact of trials on patient burden and safety.

Stay ahead of the disrupted trial landscape

Make more agile and confident decisions to keep your trial on track in the midst of disruption. By using information gathered from the real-time data, you will be well equipped to make decisions to minimize site congestion, relieve patient burden, and reduce protocol amendments.

Key Features

01 Trial, Site, and Investigator Analytics
Trial, Site, and Investigator Analytics

Trial, Site, and Investigator Analytics

Leverage historical performance metrics from 28,000+ clinical trials with granularity at the study, country, and site level and associated investigators. Rank sites based on predictive enrollment models. Assess congestion with proprietary congestion metrics. Make study enrollment duration predictions with scenario analysis.

02 Diversity
Diversity in Intelligent Trials

Diversity in Intelligent Trials

Build on your existing feasibility processes and select countries and sites that can not only help you accelerate your study, but also increase diversity. Baseline and benchmark the diversity of your trials, and set diversity goals based on industry performance in the same indication.

To learn more about our diversity offering download our fact sheet.

03 Live Study Insights
Live Study Insights

Live Study Insights

Track studies real time vs. forecasts and/or competitive industry studies at the study, country, and site level. Assess relative congestion in the vicinity of your sites from similar studies.

Diversity in Clinical Trials Research Report

The State of Black Participation in Clinical Trials

In our new research report, we set forth to assess the current state of racial diversity beyond the FDA Snapshot, using Medidata’s industry-leading clinical trial data repository. This analysis covers:

  • 972,773 trial participants
  • 4,003 global trials
  • Various levels of data granularity including global, US, TA, and site level analysis
Inclusive AI, Equitable Precision Medicine, & Diversity in Clinical Trials: Where to Begin?

Related Products

Medidata Detect

Medidata Detect

The power to proactively improve data quality and reduce trial risk



Simplify your clinical trial management workflows with a cutting-edge, configurable CTMS

Integrated Evidence

Integrated Evidence

Connect the data to increase your probability of success

Get in Touch

Interested in learning more?

Contact Sales